Jonathan Louw

Jonathan Louw, MB.ChB, MBA, is the Group CEO of Honoris United Universities, the largest Pan-African Tertiary Education Institution with over 100,000 students. He is also a member of the South African National Dept. of Health's Pricing Committee that regulates the Country's healthcare pricing and a World Economic Forum New Champions Board Member. Prior to this he was the CEO of the South African National Blood Service (SANBS), catering to the collection, processing, testing and distribution of blood and related products across South Africa. Dr. Louw worked at Adcock Ingram Holdings Limited (JSE:AIP) and was the CEO from Jan 2003 until May 2014 and led the IPO of Adcock Ingram when it separated from the JSE-Listed TigerBrands in 2008 and during his tenure the business adopted an aggressive growth strategy, re-investing in manufacturing and R&D to achieve FDA and PIC/s accreditation in both. Dr Louw first joined the pharmaceutical industry through AstraZeneca in 2000. In the 1990's he worked in the Department of Anesthesia at St. Mary's Hospital in London, having trained as an undergraduate at the University of Cape Town in the faculty of Medicine.